Human Molecular GeneticsNeurosciencePeer-reviewed journal article
Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair
Nidaa A. AbabnehiD, Jakub ScaberiD, Rowan Flynn, Andrew G. L. DouglasiD, Paola BarbagalloiD, Ana CandalijaiD, Martin R. TurneriD, David SimsiD, Ruxandra DafincaiD, Sally A. CowleyiD, Kevin TalbotiD
Abstract
The G4C2 hexanucleotide repeat expansion (HRE) in C9orf72 is the commonest cause of familial amyotrophic lateral sclerosis (ALS). A number of different methods have been used to generate isogenic control lines using CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 and non-homologous end-joining (NHEJ) by deleting the repeat region with the risk of creating indels and genomic instability. In this study we demonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72-HRE positive ALS/FTD patient using CRISPR/Cas9 genome editing and homology directed repair (HDR), resulting in replacement of the excised region with a donor template carrying the wild-type repeat size to maintain the genetic architecture of the locus. The isogenic correction of the C9orf72 HRE restored normal expression and methylation at the C9orf72 locus, reduced intron retention in the edited lines, and abolished pathological phenotypes associated with the C9orf72 HRE expansion in iPSC derived motor neurons (iPSMNs). RNA sequencing of the mutant line identified 2220 differentially expressed genes compared to its isogenic control. Enrichment analysis demonstrated an over-representation of ALS relevant pathways, including calcium ion dependent exocytosis, synaptic transport and the KEGG ALS pathway, as well as new targets of potential relevance to ALS pathophysiology. Complete correction of the C9orf72 HRE in iPSMNs by CRISPR/Cas9 mediated HDR provides an ideal model to study the earliest effects of the hexanucleotide expansion on cellular homeostasis and the key pathways implicated in ALS pathophysiology.
- organism: human
- assay: CRISPR screen
- research focus: variant calling
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 75
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro
Katharina E. Meijboom, Abbas Abdallah, … Christian Mueller·Nature CommunicationsPeer-reviewed·Oct 21, 2022
- CRISPR/Cas9-mediated generation of a de novo C9ORF72 knock-in isogenic iPSC cell bank to model ALS and FTD
Niamh Louise O’Brien, Erin C. Hedges, … Sarah Mizielinska·bioRxiv·Nov 12, 2025
- Two therapeutic CRISPR/Cas9 gene editing approaches revert FTD/ALS cellular pathology caused by a C9orf72 repeat expansion mutation in patient derived cells
Maria Sckaff, Kamaljot Gill, … Claire Dudley Clelland·bioRxiv·May 21, 2022
- CRISPR-Cas9 targeted deletion of the C9orf72 repeat expansion mutation corrects cellular phenotypes in patient-derived iPS cells
Mochtar Pribadi, Zhongan Yang, … Giovanni Coppola·bioRxiv·May 2, 2016
- NEK1 haploinsufficiency worsens DNA damage but not defective ciliogenesis in C9ORF72 patient-derived iPSC-motoneurons
Serena Santangelo, Sabrina Invernizzi, … Antonia Ratti·Human Molecular GeneticsPeer-reviewed·Sep 2, 2024
- A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis
Éric Deneault, Mathilde Chaineau, … Thomas M. Durcan·MethodsPeer-reviewed·Sep 6, 2021